Here's Why Momentum in iRadimed (IRMD) Should Keep going

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for successful short-term investing, highlighting the utility of a specific screening strategy to identify stocks with strong fundamentals and positive price momentum [1][2]. Group 1: Investment Strategy - The "Recent Price Strength" screen is designed to identify stocks with sufficient fundamental strength to maintain their upward price trends, focusing on those trading in the upper portion of their 52-week high-low range, indicating bullishness [3]. - A solid price increase of 10.6% over 12 weeks for iRadimed (IRMD) reflects investor confidence in the stock's potential upside [4]. - A price increase of 0.7% over the past four weeks indicates that the upward trend for IRMD is still intact [5]. Group 2: Stock Performance Indicators - IRMD is currently trading at 80.2% of its 52-week high-low range, suggesting it may be on the verge of a breakout [6]. - The stock holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, which are critical for near-term price movements [6]. - The Average Broker Recommendation for IRMD is 1 (Strong Buy), indicating high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Additional Insights - The article suggests that the price trend for IRMD is unlikely to reverse soon, and encourages consideration of other stocks that meet the "Recent Price Strength" criteria for potential investment [8]. - The effectiveness of stock-picking strategies can be backtested using the Zacks Research Wizard, which includes successful stock-picking strategies [9].